667 related articles for article (PubMed ID: 19582787)
1. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
[TBL] [Abstract][Full Text] [Related]
2. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-β1 regulation of ATF-3, c-Jun and JunB proteins for activation of matrix metalloproteinase-13 gene in human breast cancer cells.
Gokulnath M; Swetha R; Thejaswini G; Shilpa P; Selvamurugan N
Int J Biol Macromol; 2017 Jan; 94(Pt A):370-377. PubMed ID: 27751807
[TBL] [Abstract][Full Text] [Related]
4. Runx2, a target gene for activating transcription factor-3 in human breast cancer cells.
Gokulnath M; Partridge NC; Selvamurugan N
Tumour Biol; 2015 Mar; 36(3):1923-31. PubMed ID: 25380580
[TBL] [Abstract][Full Text] [Related]
5. MiR-4638-3p regulates transforming growth factor-β1-induced activating transcription factor-3 and cell proliferation, invasion, and apoptosis in human breast cancer cells.
Akshaya RL; Rohini M; He Z; Partridge NC; Selvamurugan N
Int J Biol Macromol; 2022 Dec; 222(Pt B):1974-1982. PubMed ID: 36208811
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells.
Kim ES; Sohn YW; Moon A
Cancer Lett; 2007 Jul; 252(1):147-56. PubMed ID: 17258390
[TBL] [Abstract][Full Text] [Related]
7. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.
Belguise K; Kersual N; Galtier F; Chalbos D
Oncogene; 2005 Feb; 24(8):1434-44. PubMed ID: 15608675
[TBL] [Abstract][Full Text] [Related]
8. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
[TBL] [Abstract][Full Text] [Related]
9. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
Sumida T; Itahana Y; Hamakawa H; Desprez PY
Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
[TBL] [Abstract][Full Text] [Related]
11. Lysyl oxidase like 4, a novel target gene of TGF-beta1 signaling, can negatively regulate TGF-beta1-induced cell motility in PLC/PRF/5 hepatoma cells.
Kim DJ; Lee DC; Yang SJ; Lee JJ; Bae EM; Kim DM; Min SH; Kim SJ; Kang DC; Sang BC; Myung PK; Park KC; Yeom YI
Biochem Biophys Res Commun; 2008 Sep; 373(4):521-7. PubMed ID: 18586005
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of ATF3 interaction with Smad4 via TGF-β1 for matrix metalloproteinase 13 gene activation in human breast cancer cells.
Rohini M; Arumugam B; Vairamani M; Selvamurugan N
Int J Biol Macromol; 2019 Aug; 134():954-961. PubMed ID: 31082421
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β1 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasion.
Wang Y; Lui WY
Eur J Cancer; 2012 Dec; 48(18):3475-87. PubMed ID: 22647687
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
Okuyama N; Matsumine A; Kosugi R; Wakabayashi H; Uchida A
Oncol Rep; 2008 Dec; 20(6):1497-504. PubMed ID: 19020733
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
16. Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells.
Kattan Z; Minig V; Leroy P; Dauça M; Becuwe P
Breast Cancer Res Treat; 2008 Mar; 108(2):203-15. PubMed ID: 17473980
[TBL] [Abstract][Full Text] [Related]
17. Identification of the functional role of AF1Q in the progression of breast cancer.
Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2008 Sep; 111(1):65-78. PubMed ID: 17929166
[TBL] [Abstract][Full Text] [Related]
18. ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells.
Safina A; Vandette E; Bakin AV
Oncogene; 2007 Apr; 26(17):2407-22. PubMed ID: 17072348
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1-stimulation of NFATC2 and ATF3 proteins and their interaction for matrix metalloproteinase 13 expression in human breast cancer cells.
Rohini M; Vairamani M; Selvamurugan N
Int J Biol Macromol; 2021 Dec; 192():1325-1330. PubMed ID: 34687766
[TBL] [Abstract][Full Text] [Related]
20. Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-beta 1) increase invasion rate of tumor cells: a population study.
Casey TM; Eneman J; Crocker A; White J; Tessitore J; Stanley M; Harlow S; Bunn JY; Weaver D; Muss H; Plaut K
Breast Cancer Res Treat; 2008 Jul; 110(1):39-49. PubMed ID: 17674196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
